Third Rock Ventures Iii, L.P. Pliant Therapeutics, Inc. (PLRX) insider trading activity

Third Rock Ventures Iii, L.P. is > 10% Shareholder of PLIANT THERAPEUTICS, INC.. Currently has a direct ownership of 1.84 Million shares of PLRX, which is worth approximately $25.9 Million. The most recent transaction as insider was on Nov 29, 2022, when has been sold 2,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.84M

0% 3M change

0% 12M change

Total Value Held $25.9 Million

Third Rock Ventures III, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 29 2022	SELL Other acquisition or disposition	-	2,000,000 Reduced 52.09%	1,839,160 Common Stock
Sep 20 2022	SELL Other acquisition or disposition	-	2,000,000 Reduced 34.25%	3,839,160 Common Stock
Jun 05 2020	BUY Conversion of derivative security	-	5,559,440 Added 48.77%	5,839,160 Common Stock

Also insider at

RLAY

Relay Therapeutics, Inc. Healthcare

> 10% Shareholder

RVMD

Revolution Medicines, Inc. Healthcare

> 10% Shareholder

NRIX

Nurix Therapeutics, Inc. Healthcare

> 10% Shareholder

VYGR

Voyager Therapeutics, Inc. Healthcare

> 10% Shareholder

FULC

Fulcrum Therapeutics, Inc. Healthcare

> 10% Shareholder

JNCE

Jounce Therapeutics, Inc. Healthcare

> 10% Shareholder

MYOK

MyoKardia Inc

> 10% Shareholder

NTGN

Neon Therapeutics, Inc.

> 10% Shareholder

TRV